RORC and neoplasm: Further work with more clinically relevant models and clinical studies are needed to address the limitations and to further support the rationale of targeting RORγ and to provide new insights into the role of RORγ in control of lipid metabolism in the tumor cells, the tumor microenvironment and the host.